Clinical Trials in Tennessee

Showing 18081-18100 of 20,239 trials

Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma

NCT00006345

RATIONALE: Denileukin diftitox may be able to deliver cancer-killing substances directly to T-cell lymphoma cells. Dexamethasone may decrease the side effects of denileukin diftitox. PURPOSE: Phase II trial to study the effectiveness of dexamethasone in preventing side effects following treatment with denileukin diftitox in treating patients who have persistent or recurrent T-cell lymphoma.

Drug/Agent Toxicity by Tissue/OrganLymphoma

Ligand PharmaceuticalsStarted Nov 1999

Miami, Florida, United States • Chicago, Illinois, United States • New Orleans, Louisiana, United States +8 more locations

COMPLETEDPhase 229 miles

Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

NCT00016926

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of capecitabine in treating patients who have advanced, persistent, or recurrent cervical cancer.

Cervical Cancer

Gynecologic Oncology GroupStarted Apr 2001

Orange, California, United States • Indianapolis, Indiana, United States • Iowa City, Iowa, United States +7 more locations

Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma

Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Find Trials by Condition in Tennessee

Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

Quality of Life in Survivors of Gynecologic Cancer

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management

A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary Disease

SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial

Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma

A Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Volunteers With Varying Degrees of Kidney Function

Single Injection of REGN475/SAR164877 in the Treatment of Chronic Pancreatitis Pain

A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.

Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes

Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer

Stress Management Training in Patients Undergoing Radiation Therapy for Cancer

Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma

Study of the Safety and Pharmacokinetics of XL765 (SAR245409) in Adults With Solid Tumors

Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)